Abstract
We evaluated 132 galactosemia patients for the Q188R (glutamine-188 to arginine) mutation in the human galactose-1-phosphate uridyltransferase (GALT) gene and for GALT activity in their hemolysates by a sensitive radioisotopic method. In those without any detectable GALT activity (GG), the Q188R mutation constituted 67% of the alleles. In patients with detectable GALT activity (GV), only 16% of the alleles were accounted for by Q188R. In all patients who were homozygous for the Q188R mutation, no erythrocyte GALT activity could be demonstrated. There was an extensive variation in the amount of detectable GALT activity ranging from 0.1% to 5% of the normal values among the GV patients. There was a difference in the frequency of Q188R mutation in the GALT alleles among patients belonging to different racial and ethnic groups. In Caucasian and Hispanic patients, the frequency was not far different (64% and 58%, respectively). On the other hand, only 12% of the GALT alleles with Q188R were found in African-American patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chacko DM, Christian JC, Nadler HL (1971) Unstable galactose-1-phosphate uridyl transferase: a new variant of galactosemia. J Pediatr 78: 454–460
Chacko CM, Wappner RS, Brandt IK, Nadler HL (1977) The Chicago variant of clinical galactosemia. Hum Genet 37: 261–279
Chakraborty R, Kamboh MI, Nwankwo M, Ferrell RE (1992) Caucasian genes in American blacks: new data. Am J Hum Genet 50: 145–155
Elsas LJ, Fridovich-Keil J, Hjelm N, Litwer S, Buist N, Tuerck J, Leslie ND, Holton J, Tyfield L (1992) Prognostication in galactosemia using molecular analysis. Am J Hum Genet 51 [Suppl]: A167
Elsas II LJ, Friedovich-Keil JL, Leslie ND (1993) Galactosemia: a molecular approach to the enigma. Int Pediatr 8: 101–109
Flach JE, Reichardt JKV, Elsas II LJ (1990) Sequence of a cDNA encoding human galactose-1-phosphate uridyl transferase Mol Biol Med 7: 365–369
Hsia DY-Y, Walker FA (1961) Variability in the clinical manifestations of galactosemia. J Pediatr 59: 872–883
Kaufman FR, Xu Yk, Ng WG, Donnel GN (1988) Correlation of ovarian function with galactose-1-phosphate uridyl transferase levels in galactosemia. J Pediatr 112: 754–756
Kaufman FR, Reichardt JKV, Ng WG, Xu Y-K, Manis FR, McBride-Chang C, Wolff JA (1994) Correlation of aspects of cognitive, neurologic and ovarian outcome with the Q188R mutation of the galactose-1-phosphate uridyltransferase gene. J Pedialr (in press)
Leslie ND, Immerman EB, Flach JE, Florez M, Fridovich-Keil JL, Elsas LJ (1992) The human galactose-1-phosphate uridyltransferase gene. Genomics 14: 474–480
Ng WG, Bergren WR, Donnell GN (1964) Galactose-1-phosphate uridyltransferase activity in galactosemia. Nature 203: 845–847
Ng WG, Xu Y-K, Kaufman FR, Donnell GN (1989) Deficit of uridine diphosphate galactose in galactosemia. J Inherit Metab Dis 12: 257–266
Ng WG, Xu Y-K, Kaufman FR, Lee JES, Donnell GN (1991) Biochemical and clinical heterogeneity among 358 galactosemia patients. In: Wilcken B, Webster D (eds) Neonatal screening in the nineties. 8th International Neonatal Screening Symposium and Inaugural Meeting of the International Society of Neonatal Screening. Leura, Australia, pp 181–188
Palmieri MJ, Berry GT, Playe DA, Roger S, Segal S (1991) The concentration of red blood cell UDPGlucose and UDPGalactose determined by high-performance liquid chromatography. Anal Biochem 194: 388–393
Reichardt JKV (1992) Genetic basis of galactosemia. Hum Mut I: 190–196
Reichardt JKV, Berg P (1988) Clonig and characterization of a cDNA encoding human galactose-1-phospate uridyl transferase. Mol Biol Med 5: 107–122
Reichardt JKV, Packman S, Woo SLC (1991) Molecular characterization of two galactosemia mutations: correlation of mutations and conserved domains in galactose-1-phosphate uridyl transferase. Am J Hum Genet 49: 860–867
Reichardt JKV, Levy HL, Woo SLC (1992) Molecular characterization of two galactosemia mutations and one polymorphism: implication for structure-function analysis of human galactose-1-phosphate uridyltransferase. Biochemistry 31: 5430–5433
Schapira F, Kaplan J (1969) Electrophoretic abnormality of galactose-1-phosphate uridyl transferase in galactosemia. Biochem Biophys Res Commun 35: 451–455
Segal S (1969) The Negro variant of congenital galactosemia. In: Hsia Y-Y (ed) Galactosemia. Thomas, Springfield, Ill, pp 176–185
Segal S (1989) Disorder of galactose metabolism. In Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 453–480
Segal S, Blair A, Roth H (1965) The metabolism of galactose by patients with congenital galactosemia. Am J Med 38: 62–70
Waggoner DD, Buist NRM, Donnell GN (1990) Long-term progosis in galactosemia: results of a survey of 350 cases. J Inherit Metab Dis 13: 802–818
Xu YK, Ng WG, Giudici T, Kaufman FR, Donnell GN (1993) Further studies of uridine diphosphate galactose (UDPGal) deficiency in galactosemia (abstract). Soc Inherit Metab Dis, Pacific Grove, California, p 46
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ng, W.G., Xu, YK., Kaufman, F.R. et al. Biochemical and molecular studies of 132 patients with galactosemia. Hum Genet 94, 359–363 (1994). https://doi.org/10.1007/BF00201593
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00201593